197 related articles for article (PubMed ID: 22409523)
1. A novel rat model for chemotherapy-induced alopecia.
Wikramanayake TC; Amini S; Simon J; Mauro LM; Elgart G; Schachner LA; Jimenez JJ
Clin Exp Dermatol; 2012 Apr; 37(3):284-9. PubMed ID: 22409523
[TBL] [Abstract][Full Text] [Related]
2. Low-level laser treatment accelerated hair regrowth in a rat model of chemotherapy-induced alopecia (CIA).
Wikramanayake TC; Villasante AC; Mauro LM; Nouri K; Schachner LA; Perez CI; Jimenez JJ
Lasers Med Sci; 2013 May; 28(3):701-6. PubMed ID: 22696077
[TBL] [Abstract][Full Text] [Related]
3. Pretreatment of epidermal growth factor promotes primary hair recovery via the dystrophic anagen pathway after chemotherapy-induced alopecia.
Paik SH; Yoon JS; Ryu HH; Lee JY; Shin CY; Min KH; Jo SJ; Kim KH; Kwon O
Exp Dermatol; 2013 Jul; 22(7):496-9. PubMed ID: 23800066
[TBL] [Abstract][Full Text] [Related]
4. A guide to assessing damage response pathways of the hair follicle: lessons from cyclophosphamide-induced alopecia in mice.
Hendrix S; Handjiski B; Peters EM; Paus R
J Invest Dermatol; 2005 Jul; 125(1):42-51. PubMed ID: 15982301
[TBL] [Abstract][Full Text] [Related]
5. Topical calcitriol enhances normal hair regrowth but does not prevent chemotherapy-induced alopecia in mice.
Paus R; Schilli MB; Handjiski B; Menrad A; Henz BM; Plonka P
Cancer Res; 1996 Oct; 56(19):4438-43. PubMed ID: 8813138
[TBL] [Abstract][Full Text] [Related]
6. Hair growth modulation by topical immunophilin ligands: induction of anagen, inhibition of massive catagen development, and relative protection from chemotherapy-induced alopecia.
Maurer M; Handjiski B; Paus R
Am J Pathol; 1997 Apr; 150(4):1433-41. PubMed ID: 9094998
[TBL] [Abstract][Full Text] [Related]
7. Laminin-511, inducer of hair growth, is down-regulated and its suppressor in hair growth, laminin-332 up-regulated in chemotherapy-induced alopecia.
Imanishi H; Tsuruta D; Tateishi C; Sugawara K; Paus R; Tsuji T; Ishii M; Ikeda K; Kunimoto H; Nakajima K; Jones JC; Kobayashi H
J Dermatol Sci; 2010 Apr; 58(1):43-54. PubMed ID: 20211547
[TBL] [Abstract][Full Text] [Related]
8. Preventive effects of cedrol against alopecia in cyclophosphamide-treated mice.
Chen SS; Zhang Y; Lu QL; Lin Z; Zhao Y
Environ Toxicol Pharmacol; 2016 Sep; 46():270-276. PubMed ID: 27522546
[TBL] [Abstract][Full Text] [Related]
9. Treatment and prevention of chemotherapy-induced alopecia with PTH-CBD, a collagen-targeted parathyroid hormone analog, in a non-depilated mouse model.
Katikaneni R; Ponnapakkam T; Matsushita O; Sakon J; Gensure R
Anticancer Drugs; 2014 Jan; 25(1):30-8. PubMed ID: 24025564
[TBL] [Abstract][Full Text] [Related]
10. Protection against chemotherapy-induced alopecia by cyclosporin A in the newborn rat animal model.
Hussein AM; Stuart A; Peters WP
Dermatology; 1995; 190(3):192-6. PubMed ID: 7599379
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy-induced alopecia in mice. Induction by cyclophosphamide, inhibition by cyclosporine A, and modulation by dexamethasone.
Paus R; Handjiski B; Eichmüller S; Czarnetzki BM
Am J Pathol; 1994 Apr; 144(4):719-34. PubMed ID: 8160773
[TBL] [Abstract][Full Text] [Related]
12. Development of a Model for Chemotherapy-Induced Alopecia: Profiling of Histological Changes in Human Hair Follicles after Chemotherapy.
Yoon JS; Choi M; Shin CY; Paik SH; Kim KH; Kwon O
J Invest Dermatol; 2016 Mar; 136(3):584-92. PubMed ID: 26774950
[TBL] [Abstract][Full Text] [Related]
13. Prevention of chemotherapy-induced alopecia in rats by CDK inhibitors.
Davis ST; Benson BG; Bramson HN; Chapman DE; Dickerson SH; Dold KM; Eberwein DJ; Edelstein M; Frye SV; Gampe RT; Griffin RJ; Harris PA; Hassell AM; Holmes WD; Hunter RN; Knick VB; Lackey K; Lovejoy B; Luzzio MJ; Murray D; Parker P; Rocque WJ; Shewchuk L; Veal JM; Walker DH; Kuyper LF
Science; 2001 Jan; 291(5501):134-7. PubMed ID: 11141566
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapy-induced alopecia.
Trüeb RM
Semin Cutan Med Surg; 2009 Mar; 28(1):11-4. PubMed ID: 19341937
[TBL] [Abstract][Full Text] [Related]
15. Human placenta induces hair regrowth in chemotherapy-induced alopecia via inhibition of apoptotic factors and proliferation of hair follicles.
Kim MH; Kim K; Lee H; Yang WM
BMC Complement Med Ther; 2020 Jul; 20(1):230. PubMed ID: 32689985
[TBL] [Abstract][Full Text] [Related]
16. Prevention of chemotherapy-induced alopecia by the anti-death FNK protein.
Nakashima-Kamimura N; Nishimaki K; Mori T; Asoh S; Ohta S
Life Sci; 2008 Jan; 82(3-4):218-25. PubMed ID: 18164732
[TBL] [Abstract][Full Text] [Related]
17. 'Atrophic telogen effluvium' from cytotoxic drugs and a randomized controlled trial to investigate the possible protective effect of pretreatment with a topical vitamin D analogue in humans.
Bleiker TO; Nicolaou N; Traulsen J; Hutchinson PE
Br J Dermatol; 2005 Jul; 153(1):103-12. PubMed ID: 16029334
[TBL] [Abstract][Full Text] [Related]
18. α-Melanocyte-stimulating hormone: a protective peptide against chemotherapy-induced hair follicle damage?
Böhm M; Bodó E; Funk W; Paus R
Br J Dermatol; 2014 Apr; 170(4):956-60. PubMed ID: 24341930
[TBL] [Abstract][Full Text] [Related]
19. Parathyroid hormone linked to a collagen binding domain promotes hair growth in a mouse model of chemotherapy-induced alopecia in a dose-dependent manner.
Katikaneni R; Ponnapakkam T; Seymour A; Sakon J; Gensure R
Anticancer Drugs; 2014 Aug; 25(7):819-25. PubMed ID: 24710191
[TBL] [Abstract][Full Text] [Related]
20. Cytoprotective role of human dental pulp stem cell-conditioned medium in chemotherapy-induced alopecia.
Chen H; Yamaguchi S; Wang Y; Kaminogo K; Sakai K; Hibi H
Stem Cell Res Ther; 2024 Mar; 15(1):84. PubMed ID: 38500206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
